Current investigational drugs for major depression
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543780902880850
Reference200 articles.
1. Research and treatment approaches to depression
2. From monoamines to genomic targets: a paradigm shift for drug discovery in depression
3. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists
4. Behavior Therapy for Obsessive-Compulsive Disorder Guided by a Computer or by a Clinician Compared With Relaxation as a Control
5. The Epidemiology of Major Depressive Disorder
Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of brain estrogen receptor on depression and its mechanism of action;Guidelines and Standards of Chinese Medicine;2024-07-24
2. The efficacy and safety of Zuranolone for treatment of depression: A systematic review and meta-analysis;Psychopharmacology;2024-05-28
3. Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon;Cancers;2024-04-27
4. Stimuli-responsive nanoparticles delivered by a nasal-brain pathway alleviate depression-like behavior through extensively scavenging ROS;Acta Biomaterialia;2023-11
5. Etiopathogenesis of depression and experimental depression models used in preclinical studies;European Journal of Life Sciences;2023-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3